drugset / Trial / NCT06148948
A Study in Healthy Men to Test How Well Different Doses of BI 1584862 Are Tolerated
RandomizedParallel-groupSingle-blindTreatment
Summary
The goal of this trial is to investigate safety, tolerability and pharmacokinetics of BI 1584862 in healthy male subjects of Japanese ethnicity following oral administration of single rising doses.
Timeline
- Start
- 2023-12-25
- Primary completion
- 2024-05-21
- Completion
- 2024-05-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 1584862 | Unknown | — | Oral |
Indications
No indication recorded.